Home / Docetaxel / Switzerland
CH ATC L01CD02 · updated 2 Nov 2026
Docetaxel shortage in Switzerland
Is there a Docetaxel shortage in Switzerland?
Yes. As of 2 Nov 2026, 4 Docetaxel products are reported short in Switzerland, the first since 6 Mar 2026. The company estimate for the return is 6 Nov 2026 (latest 4 Dec 2026). Main reason: not stated.
Also short in United States, Canada, Italy, Spain, Belgium, Sweden, Australia. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | DOCETAXEL Teva liquid Inf Konz 140 mg/7ml Durchstf | Teva Pharma AG | 6 Mar 2026 | 6 Nov 2026 | Not stated |
| CH | DOCETAXEL Teva liquid Inf Konz 20 mg/1ml Durchstf | Teva Pharma AG | 6 Mar 2026 | 6 Nov 2026 | Not stated |
| CH | DOCETAXEL Accord 160 mg/8 ml Konz Inf 160 mg 1 Stk | Accord Healthcare AG | 4 Jun 2026 | 13 Nov 2026 | Not stated |
| CH | DOCETAXEL Teva liquid Inf Konz 80 mg/4ml Durchstf | Teva Pharma AG | 18 Sep 2026 | 4 Dec 2026 | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).